Cookies:
This website intends to use cookies to improve the site and your experience. By continuing to browse the site, you are agreeing to accept our use of cookies . If you require further information and/or do not wish to have cookies placed when using the site, you can modify your browser settings appropriately, or you may visit our internet privacy page .
Home
Biogen is one of the world’s leading biotechnology companies, with a focus on developing therapies for serious neurological, autoimmune and rare diseases.
x
About Us
At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.
Learn more about Biogen
x
Research & Pipeline
We aspire to have the greatest impact on patients and science of any biotechnology company in the history of our industry. To us, that means creating novel medicines that benefit individuals and society, and bringing new scientific understanding to diseases for which there are no adequate treatments.
See what we are working on
x
Therapies
We develop medicines for serious medical conditions with few or no treatment options. Every day, we work to bring patients better outcomes and advance their standard of care.
Explore our therapeutic areas
x
Responsibility
Working to make a positive impact for patients, the communities where we work and live, and for society.
Read more
x
Careers
Explore career opportunities at Biogen, and experience the fulfillment that comes from helping to discover, manufacture and market new treatments for patients
Read more
x
Investors
Find Biogen’s current and historical stock information. View our upcoming events and latest webcasts. Find financial statements and reports.
Read more
x
Terms & conditions
These terms and conditions of use describe the terms and conditions applicable to your use of Biogen Idec Ltd.’s (“Biogen”) website. Find out more.
x